Profit Or Loss [Abstract]

ERYTECH Pharma S.A. - Filing #880081

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
EUR
EUR
EUR
Other income
4 180 EUR
3 718 EUR
5 283 EUR
Profit (loss) from operating activities
56 515 EUR
68 832 EUR
64 074 EUR
Finance income
5 422 EUR
889,000 EUR
2 947 EUR
Finance costs
2 702 EUR
5 354 EUR
1 533 EUR
Tax expense (income)
2,000 EUR
3,000 EUR
1,000 EUR
Profit (loss)
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
62 659 EUR
62 659 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
227.00
399.00
349.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.